A Laboratory-Based Study on Multiple Biomarker Testing in the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): Real-Life Data.

Lass-Flörl, Cornelia; Knoll, Miriam; Posch, Wilfried; Joannidis, Michael; Mayerhöfer, Timo; Breitkopf, Robert; Bellmann, Romuald

Lass-Flörl, Cornelia; Knoll, Miriam; Posch, Wilfried; Joannidis, Michael; Mayerhöfer, Timo; Breitkopf, Robert; Bellmann, Romuald.

Afiliação

Lass-Flörl C; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Knoll M; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Posch W; Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Joannidis M; Department of Internal Medicine, Division of Intensive Care and Emergency Medicine, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Mayerhöfer T; Department of Internal Medicine, Division of Intensive Care and Emergency Medicine, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Breitkopf R; Department of Anaesthesia and Intensive Care, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Bellmann R; Department of Internal Medicine, Division of Intensive Care and Emergency Medicine, Medical University of Innsbruck, A-6020 Innsbruck, Austria.

Diagnostics (Basel) ; 13(1)2022 Dec 30.

Article em En | MEDLINE | ID: mdl-36611406

Palavras-chave

Aspergillus; Aspergillus PCR; CAPA; conventional diagnostics in aspergillosis; galactomannan enzyme immunoassay

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google